|

Oxytocin nasal spray Clinical Trials

4 actively recruiting trials across 1 location

Also known as: Syntocin, Syntocinon

Pipeline

Phase 2: 3Phase 2/3: 1

Top Sponsors

  • University Hospital, Basel, Switzerland2
  • Massachusetts General Hospital1
  • Dr. Karin Hediger1

Indications

  • Arginine Vasopressin Deficiency2
  • Diabetes2
  • Human-Animal Interaction1
  • Oxytocin1
  • Obesity, Adolescent1

Other3 trials

Dog Presence and Oxytocin on Trust Towards Therapists
Phase 2/3
Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls
Phase 2
Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls
Phase 2

Boston, Massachusetts1 trial

Oxytocin for Weight Loss in Adolescents

Massachusetts General Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.